NCT04914520View on ClinicalTrials.gov

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 11, 2021

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL

VN-0200

VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

BIOLOGICAL

Placebo

Placebo administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Trial Locations (1)

160-0017

Medical Corporation Association Shinanokai Shinanozaka Clinic, Shinjuku-Ku

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT04914520 - Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects | Biotech Hunter | Biotech Hunter